Form 4: Teladoc Executive Adjusts Holdings
Insider Transaction Report
Fernando Rodrigues, President of BetterHelp, reported transactions involving Teladoc Health, Inc. common stock and restricted stock units.
Summary
- Fernando Rodrigues, President of BetterHelp, reported a series of transactions on June 1st and June 2nd, 2026.
- These transactions involved the conversion and sale of restricted stock units (RSUs) into common stock.
- Specifically, 5,491 RSUs were converted and disposed of, followed by 1,042 RSUs and then 8,716 RSUs.
- On June 2nd, 5,677 shares of common stock were sold at a price of $7.627 per share.
- Following these transactions, Rodrigues beneficially owns 9,572 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine insider stock transactions related to equity compensation rather than significant strategic shifts or performance indicators.
Positives
- The reporting person successfully converted and disposed of restricted stock units, potentially realizing value.
- A portion of the transactions were to cover tax withholding obligations, indicating a normal course of business for equity compensation.
Negatives
- The sale of 5,677 shares of common stock at $7.627 per share may indicate a reduction in the reporting person's direct stake in the company.
Future Outlook
The filing details the vesting schedules of previously granted restricted stock units, indicating future potential conversions and dispositions of common stock.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock dealings within the telehealth and digital health sector.
Stakeholder Impact
- Shareholders: The sale of shares by an executive may be interpreted in various ways, but in this context, it appears to be related to covering tax obligations from equity compensation vesting.
Next Steps
- Continued vesting and potential conversion/disposition of remaining restricted stock units according to their respective schedules.
Key Dates
| Date | Description |
|---|---|
| 2023-12-01 | Grant date for 65,894 restricted stock units to Fernando Rodrigues. |
| 2024-03-19 | Grant date for 12,500 restricted stock units to Fernando Rodrigues. |
| 2025-03-01 | Grant date for 104,602 restricted stock units to Fernando Rodrigues. |
| 2025-06-01 | Start date for quarterly vesting installments for a portion of RSUs granted on March 19, 2024. |
| 2026-03-01 | Vesting date for one-third of RSUs granted on March 1, 2025. |
| 2026-06-01 | Earliest transaction date reported; conversion and disposition of RSUs. |
| 2026-06-02 | Date of common stock sale transaction. |
| 2026-06-03 | Date of filing signature. |
Keywords
Form 4, SEC Filing, Teladoc Health, TDOC, Fernando Rodrigues, Restricted Stock Units, Common Stock, Insider Trading, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.